BIOSENSE WEBSTER INC EZ STEER THERMOCOOL NAV BI-DIRECTIONAL CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER
|
Back to Search Results |
|
Model Number BNI75TCDFH |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problem
Cardiac Tamponade (2226)
|
Event Date 10/07/2021 |
Event Type
Injury
|
Event Description
|
It was reported that an (b)(6) female patient ((b)(6)) underwent an atrial fibrillation (afib) ablation procedure with a ez steer¿ thermocool® nav bi-directional catheter and the patient suffered cardiac tamponade requiring pericardiocentesis and surgical intervention.Pericardial effusion was detected during treatment, during use of biosense webster products, and treatment was discontinued.Cardiac tamponade was diagnosed and drainage was performed, but hemostasis could not be achieved, so thoracotomy was performed.The physician commented that it may be due to steam pop.The operation was successfully completed and the patient was resting.The physician commented that since there was a hole in the site different from the site where it noticed the steam pop, it was suspected to be due to excessive ablation at a different site from the steam pop site.Additional information was received which indicated the physician¿s opinion on the cause of this adverse event is that it was procedure related.Drainage and thoracotomy were performed for intervention.Patient outcome from the adverse event was reported as improved.Prior to noting the cardiac tamponade (ct) ablation had already performed.No error messages observed on biosense webster equipment during the procedure.
|
|
Manufacturer Narrative
|
Device investigation details: the device has been reported as discarded, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation was performed for the finished device 30594523m number, and no internal action related to the complaint was found during the review.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.(b)(6).If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.(b)(4).
|
|
Search Alerts/Recalls
|
|
|